Acurx Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Acurx Pharmaceuticals

12/05/2023 14:32

* Acurx Pharmaceuticals Inc  ACXP.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 29 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acurx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 25 cents​.
    * The mean earnings estimate of analysts had risen by
about 15.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Acurx Pharmaceuticals Inc shares had fallen by 4.3% this
quarter and lost 16.8% so far this year.
    * The company reported a quarterly loss of $2.9 million.
    * Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.29          -0.25          Beat
 Dec. 31 2022      -0.35          -0.28          Beat
 Sep. 30 2022      -0.28          -0.32          Missed